Medication-overuse headache in China: Clinical profile, and an evaluation of the ICHD-3 beta diagnostic criteria

Cephalalgia

Volumn 35, Issue 8, 2015, Pages 644-651

  Dong, Zhao ^a   Chen, Xiaoyan ^a   Steiner, Timothy J ^b,c   Hou, Lei ^a   Di, Hai ^a   He, Mianwang ^a   Dai, Wei ^a   Pan, Meiyan ^a   Zhang, Mingjie ^a   Liu, Ruozhuo ^a   Yu, Shengyuan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

China; clinical features; diagnostic criteria; ICHD 3 beta; Medication overuse headache

Indexed keywords

ACETAMINOPHEN PLUS ACETYLSALICYLIC ACID PLUS CAFFEINE; ACETAMINOPHEN PLUS ACETYLSALICYLIC ACID PLUS PHENACETIN; ACETYLSALICYLIC ACID; AMINOPHENAZONE; AMINOPYRINE PLUS CAFFEINE; AMINOPYRINE PLUS CAFFEINE PLUS PHENACETIN PLUS PHENOBARBITAL; ANALGESIC AGENT; ANTIPYRINE PLUS CAFFEINE; CAFFEINE; CHLORPHENIRAMINE MALEATE; CHLORPHENIRAMINE MALEATE PLUS DICLOFENAC SODIUM; CODEINE; ERGOTAMINE; IBUPROFEN; PARACETAMOL; PHENACETIN; PHENAZONE; PHENOBARBITAL; TRAMADOL; TRIPTAN DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHINA; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG INDUCED HEADACHE; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HUMAN; INCOME; INTERNATIONAL CLASSIFICATION OF HEADACHE DISORDERS SECOND EDITION; INTERNATIONAL CLASSIFICATION OF HEADACHE DISORDERS SECOND EDITION REVISED; INTERNATIONAL CLASSIFICATION OF HEADACHE DISORDERS THIRD EDITION BETA; MAJOR CLINICAL STUDY; MALE; MIGRAINE; ONSET AGE; QUALITY OF LIFE; RETROSPECTIVE STUDY; TENSION HEADACHE; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; VISUAL ANALOG SCALE; AGED; HEADACHE DISORDERS, SECONDARY; INTERNATIONAL CLASSIFICATION OF DISEASES; MIDDLE AGED;

ADULT; AGED; CHINA; FEMALE; HEADACHE DISORDERS, SECONDARY; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED;

EID: 84930809143     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102414552533     Document Type: Article

References (23)

1. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004 ; 24: 60-63
2. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 ; 26: 742-746
3. Colás R, Muñoz P, Temprano R, et al. Chronic daily headache with analgesic overuse: Epidemiology and impact on quality of life. Neurology. 2004 ; 62: 1338-1342
4. Diener HC, Limmroth V. Medication-overuse headache: A worldwide problem. Lancet Neurol. 2004 ; 3: 475-483
5. Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol. 2010 ; 9: 391-401
6. Katsarava Z, Obermann M. Medication-overuse headache. Curr Opin Neurol. 2013 ; 26: 276-281
7. Katsarava Z, Holle D, Diener HC. Medication overuse headache. Curr Neurol Neurosci Rep. 2009 ; 9: 115-119
8. Yu S, Liu R, Zhao G, et al. The prevalence and burden of primary headaches in China: A population-based door-to-door survey. Headache. 2012 ; 52: 582-591
9. Ayzenberg I, Katsarava Z, Sborowski A, et al. The prevalence of primary headache disorders in Russia: A countrywide survey. Cephalalgia. 2012 ; 32: 373-381
10. Westergaard ML, Hansen EH, Glümer C, et al. Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: A systematic review. Cephalalgia. 2014 ; 34: 409-425
11. Linde M, Gustavsson A, Stovner LJ, et al. The cost of headache disorders in Europe: The Eurolight project. Eur J Neurol. 2012 ; 19: 703-711
12. Scher AI, Stewart WF, Ricci JA, et al. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003 ; 106: 81-89
13. Lu SR, Fuh JL, Chen WT, et al. Chronic daily headache in Taipei, Taiwan: Prevalence, follow-up and outcome predictors. Cephalalgia. 2001 ; 21: 980-986
14. Kanki R, Nagaseki Y, Sakai F. Medication-overuse headache in Japan. Cephalalgia. 2008 ; 28: 1227-1228
15. Imai N, Kitamura E, Konishi T, et al. Clinical features of probable medication-overuse headache: A retrospective study in Japan. Cephalalgia. 2007 ; 27: 1020-1023
16. Ravishankar K. Medication overuse headache in India. Cephalalgia. 2008 ; 28: 1223-1226
17. Steiner T. Can we know the prevalence of MOH?. Cephalalgia. 2014 ; 34: 403-404
18. Dong Z, Di H, Dai W, et al. Application of ICHD-II criteria in a headache clinic of China. PLoS One. 2012 ; 7: e50898 - e50898
19. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013 ; 33: 629-808
20. Schmidt S, Mühlan H, Power M. The EUROHISQOL 8-item index: Psychometric results of a cross-cultural field study. Eur J Public Health. 2006 ; 16: 420-428
21. Atasoy HT, Unal AE, Atasoy N, et al. Low income and education levels may cause medication overuse and chronicity in migraine patients. Headache. 2005 ; 45: 25-31
22. The World Bank. Data China, http://data.worldbank.org/country/china (accessed 26 June 2014).
23. Bigal ME, Serrano D, Buse D, et al. Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study. Headache. 2008 ; 48: 1157-1168